EFA Stock Chart Fri, Jan 3rd, 2014

New Post Public Reply Private Reply Replies (0) Message Board
chartguy89
EFA Stock Chart and Technical Analysis - Fri, Jan 3rd, 2014 $EFA

Period  Moving Average  Price Change  Percent Change  Average Volume
5 Day  66.48  -0.25  -0.38%  20,042,791
20 Day  65.33  +1.04  +1.60%  16,019,033
50 Day  65.63  -0.86  -1.29%  15,950,805
100 Day  64.28  +4.31  +6.99%  15,604,043
200 Day  62.29  +6.59  +11.10%  17,145,934
Year to Date  65.95  -1.12  -1.67%  22,745,828

Period  Raw Stochastic  Stochastic %K  Stochastic %D  Average True Range
9 Day 44.36% 62.77% 78.92% 0.58
14 Day 64.25% 73.32% 83.74% 0.56
20 Day 64.25% 73.32% 83.74% 0.56
50 Day 64.25% 73.32% 83.58% 0.58
100 Day 83.17% 87.44% 92.28% 0.61

Period  Relative Strength  Percent R  Historic Volatility  MACD Oscillator
9 Day 53.56% 55.64% 11.79% +0.18
14 Day 53.91% 35.75% 10.40% +0.79
20 Day 53.83% 35.75% 11.14% +1.00
50 Day 54.54% 35.75% 10.17% +0.70
100 Day 54.59% 16.83% 12.06% +2.05

EFA Stock Chart and Technical Analysis - Fri, Jan 3rd, 2014
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib

Updated Category News Views 264

Promising Advances in Breast Cancer Treatment Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a pioneering biopharmaceutical company specializing in breast cancer therapies, recently revealed compelling data from its Phase 1b/2 trial examining the effects of palazestrant combined with ribociclib in patients battling estrogen...

Continue Reading
Recent Share Transactions by Danske Bank Management Team

Updated Category News Views 135

Recent Share Transactions by Danske Bank Management Team Danske Bank A/S has been making headlines with its ongoing share buy-back program, a key strategic move aimed at enhancing shareholder value. As management and executives involve themselves in these transactions, it is essential to stay informed about their actions, which are a reflection of the company's health and...

Continue Reading
Purpose Legal's PurposeXi: AI-Driven Legal Revolution or Just Hype?

Updated Category News Views 171

Purpose Legal just unveiled PurposeXi™ on February 17, 2026—this shiny new tool aims to revolutionize the legal landscape by integrating AI across the board. Traders are raising eyebrows because while they tout speed and efficiency, we've seen this play before. Remember when tech made bold claims but left investors hanging when reality hit? Well, buckle up....

Continue Reading
PowerBank's Vision for Dominating the Data Center Industry

Updated Category News Views 138

Insight into the Data Center Market PowerBank Corporation (NASDAQ: SUUN) is stepping into the spotlight as a key player in the rapidly expanding data center market. The company is poised to leverage its expertise in energy infrastructure development and asset ownership to address the rising demand for power supply in data centers. Projections suggest that the data center...

Continue Reading
Exploring the Promising Landscape of Adenosine Antagonists

Updated Category News Views 156

Introduction to Adenosine Antagonists Adenosine antagonists represent a fascinating domain in medical research, particularly due to their potential implications across various therapeutic areas. As these compounds inhibit adenosine—a nucleoside that governs essential physiological functions—they may revolutionize treatment options for diseases such as cancer,...

Continue Reading